INBX compared with MGTX: revenue, margins and what each company keeps, and the suppliers and customers both name

INBXInhibrx Biosciences, Inc.

Mkt capRevenueRevenue

MGTXMeiraGTx Holdings plc

Mkt capRevenueRevenue

Compare

INBXInhibrx Biosciences, Inc.

MGTXMeiraGTx Holdings plc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

INBXInhibrx Biosciences, Inc.

71.78▼−0.01%· post 72.24· delayed

Mkt cap$1.1BRevenue$1MQ2 FY25Revenue—

MGTXMeiraGTx Holdings plc

9.45▼−0.44%· post 9.32· delayed

After hoursNov 2 '26delayed

Mkt cap$911.4MRevenue$321MQ2 FY26Revenue$81MFY25

Compare

After hoursNov 2 '26delayed

INBXInhibrx Biosciences, Inc.

MGTXMeiraGTx Holdings plc

71.78▼−0.01%post 72.24delayed

Price

9.45▼−0.44%post 9.32delayed

$1.1B

Mkt cap

$911.4M

Q2 FY25$1M

Revenue

$321MQ2 FY26

—

Revenue

$81MFY25

INBX71.78▼−0.01%vsMGTX9.45▼−0.44%After hoursNov 2 '26delayed

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

INBX: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only INBX 4

REGNRegeneron Pharmaceuticalscustomer

SNYSanoficustomer

—Scitheraunlistedcustomer

—Art Acquisition Subunlistedcustomer

Shared 0

No shared counterparties.

Only MGTX 8

LLYEli Lillycustomer

JNJJohnson & Johnson Innovative Medicinecustomer

—UCL Business Plc (UCLB)unlistedsupplier

—Brandeis University

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

unlistedsupplier

4 more · MGTX chain ›

Price

rebased to 0%

INBX, solidMGTX, dashed